S. Perna

发表

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application

C. Rooney, L. Rollins, A. Gee, 2015, Journal of Immunotherapy for Cancer.

Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma

H. Heslop, C. Rooney, M. Brenner, 2012, Clinical Cancer Research.

Management of patients with non-Hodgkin’s lymphoma: focus on adoptive T-cell therapy

B. Savoldo, L. Huye, S. Perna, 2015, ImmunoTargets and therapy.

Genetic modification of cytotoxic T lymphocytes to express cytokine receptors.

B. Savoldo, G. Dotti, S. Perna, 2014, Methods in molecular biology.

Interleukin-7 Mediates Selective Expansion of Tumor-redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-cell Inhibition

Hao Liu, M. Brenner, Aruna Mahendravada, 2013, Clinical Cancer Research.

Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.

C. Bordignon, M. Ponzoni, C. Tresoldi, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer

R. Drezek, A. Foster, A. Lin, 2013, PloS one.

Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations.

C. Bordignon, C. Tresoldi, F. Ciceri, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Loss of mismatched HLA in leukemia after stem-cell transplantation.

Federica Torri, C. Barlassina, M. Roncarolo, 2009, The New England journal of medicine.

Genomic Loss of the Mismatched HLA Locus in Leukemia Is a Major Mechanism of in Vivo Escape from T Cell Immunosurveillance Following Haploidentical HSCT

M. Roncarolo, C. Bordignon, F. Ciceri, 2008 .

Pharmacodynamics (PD) and genomic profiling of pts treated with cabiralizumab (cabira) + nivolumab (NIVO) provide evidence of on-target tumor immune modulations and support future clinical applications.

M. Carleton, Z. Wainberg, S. Piha-Paul, 2018 .

Correction: Interleukin-7 Mediates Selective Expansion of Tumor-Redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-Cell Inhibition

M. Brenner, Aruna Mahendravada, B. Savoldo, 2014, Clinical Cancer Research.

Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design.

A. Schambach, Claudia Cattoglio, F. Mavilio, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections

U. Gerdemann, H. Heslop, C. Rooney, 2012, Molecular Therapy.

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

A. Ganser, P. Bruzzi, A. Santoro, 2009, The Lancet. Oncology.

The suicide gene therapy challenge: how to improve a successful gene therapy approach.

Chiara Bonini, C. Bordignon, F. Ciceri, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

M. Sormani, D. Middleton, M. Roncarolo, 2008, Blood.

Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease

Helen E. Heslop, Cliona M. Rooney, Juan F. Vera, 2013, Haematologica.

5′-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells

M. Garcia-Gil, R. Pesi, M. Camici, 2003, Neuroscience.

Proceedings of the 7th Biannual International Symposium on Nasopharyngeal Carcinoma 2015

Sugiyanto, Asma Abdul Rahman, C. Lemmen, 2016, BMC Proceedings.

A randomized phase II study of cabiralizumab (cabira) + nivolumab (nivo) ± chemotherapy (chemo) in advanced pancreatic ductal adenocarcinoma (PDAC).

T. Seufferlein, Z. Wainberg, J. Bendell, 2019, Journal of Clinical Oncology.

Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study

P. Riedell, D. Maloney, D. Brander, 2023, The Lancet.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.